Expert NetworkExpert InterviewSRRK

Slingshot members are talking to an expert! The topic is:

A Second Opinion: Looking at the recent Phase 3 results on Scholar Rock's apitegromab for Spinal Muscular Atrophy

Executed on:Oct 22, 2024 6:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Tennessee Medical Center
  • Neuromuscular specialist at UTMC
  • Manages several patients with Spinal Muscular Atrophy 
  • Previous investigator on several neuromuscular clinical trials with a special interest in Chronic Inflammatory Demyelinating Polyneuropathy and Peripheral Neuropathy.

Interview Goal

Discussing expectations for apitegromab with a neurologist

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.